Showing results (11-20 of 72) with videos related to
Sort By:
Pageof 8
Expert Opinion on Drug Safety|December 17, 2009
Platelet count less than SHARP: what does a case series reveal?M Wasif SaifTherapeutics and Clinical Risk Management|March 25, 2008
Management of oxaliplatin-induced peripheral neuropathyM Wasif Saif, John ReardonClinical Colorectal Cancer|March 4, 2006
Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency?M Wasif Saif, Robert DiasioExpert Opinion on Drug Safety|March 21, 2007
Incidence and management of cutaneous toxicities associated with cetuximabM Wasif Saif, Richard KimClinical Advances in Hematology & Oncology : H&O|March 11, 2009
K-ras mutations in colorectal cancer: a practice changing discoveryM Wasif Saif, Manasi ShahExpert Opinion on Drug Safety|June 16, 2006
Incidence and management of bevacizumab-related toxicities in colorectal cancerM Wasif Saif, Ranee MehraCurrent Opinion in Oncology|November 13, 2014
Pancreatic neuroendocrine tumors: targeting the molecular basis of diseaseSimon Khagi, M Wasif SaifClinical Colorectal Cancer|June 3, 2005
Edotecarin: a novel topoisomerase I inhibitorM Wasif Saif, Robert B DiasioClinical Investigation|July 7, 2015
Novel oral taxane therapies: recent Phase I resultsJohn Paul Flores, M Wasif SaifClinical Medicine Insights. Oncology|January 19, 2012
Safety and efficacy of everolimus in adult patients with neuroendocrine tumorsPaul E Oberstein, M Wasif SaifPageof 8